​

Caris Life Sciences Ownership | Who Owns Caris Life Sciences?

OverviewRevenueFinancialsChartTranscripts

Caris Life Sciences Ownership Summary

Caris Life Sciences is owned by 616.65% institutional investors, 48.16% insiders. Sixth street partners management company is the largest institutional shareholder, holding 37.56% of CAI shares.

CAI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCaris Life Sciences616.65%48.16%-564.80%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sixth street partners management company24.39M37.56%$737.66M
Coatue management10.14M15.62%$306.80M
Fmr9.63M14.84%$291.41M
T. rowe price investment management8.03M12.36%$242.78M
Braidwell lp7.32M11.27%$221.31M
Price t rowe associates inc /md/6.92M10.67%$209.47M
Silver lake group5.29M8.15%$160.05M
Neuberger berman group4.35M6.69%$109.08M
Pointstate capital lp3.88M5.98%$117.48M
Orbimed advisors3.03M4.67%$91.80M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sixth street partners management company24.39M63.36%$737.66M
Pura vida investments89.94K16.58%$2.72M
Braidwell lp7.32M6.57%$221.31M
Longaeva partners1.29M5.61%$38.90M
Silver lake group5.29M3.12%$160.05M
Orbimed advisors3.03M2.16%$91.80M
Pointstate capital lp3.88M1.75%$117.48M
Rock springs capital management lp793.65K1.40%$24.01M
Point72 (difc)654.79K1.30%$19.81M
First light asset management403.92K1.12%$11.88M

Top Buyers

HolderShares% AssetsChange
Pointstate capital lp3.88M1.75%1.39M
Fmr9.63M0.02%1.00M
Lord, abbett850.00K0.08%850.00K
Morgan stanley1.53M0.00%729.18K
Alyeska investment group1.10M0.10%725.07K

Top Sellers

HolderShares% AssetsChange
Neuberger berman group4.35M0.08%-1.89M
Capital world investors---999.95K
Woodline partners lp723.16K0.10%-523.16K
Franklin resources216.96K0.00%-310.07K
Summit partners public asset management---296.00K

New Positions

HolderShares% AssetsChangeValue
Lord, abbett850.00K0.08%850.00K$25.71M
Ubs group235.87K0.00%235.87K$7.14M
Renaissance225.10K0.01%225.10K$6.81M
Lazard asset management169.93K0.01%169.93K$4.54M
State street155.34K0.00%155.34K$4.70M

Sold Out

HolderChange
Olistico wealth-1.03K
Sectoral asset management-8.35K
Weiss asset management lp-10.00K
Bank of montreal /can/-10.00K
Quarry lp-10.62K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025117-106,907,974-616-117---
Dec 31, 20211-99.25%1,399-99.99%-0.00%--100.00%--100.00%
Sep 30, 2021133-13.07%15,280,7190.15%881.13%63-16.00%46-14.81%
Jun 30, 20211534.08%15,257,6658.40%881.33%75-12.79%5428.57%
Mar 31, 202114723.53%14,075,013-5.87%811.14%8617.81%4250.00%

Recent Insider Transactions

DateNameRoleActivityValue
Nov 07, 2025Denton John Russel See RemarksBuy$100.79K
Nov 07, 2025Spetzler David Baxley PresidentBuy$9.54K
Mar 29, 2019Sawka Gary-Sell$232.30K
Feb 26, 2019Garcia Victor President and CEOBuy$233.70K
Feb 27, 2019Garcia Victor President and CEOBuy$2.27K

CAI Ownership FAQ

Who Owns Caris Life Sciences?

Caris Life Sciences shareholders are primarily institutional investors at 616.65%, followed by 48.16% insiders and -564.81% retail investors. The average institutional ownership in Caris Life Sciences's industry, Biotech Stocks , is 295.31%, which Caris Life Sciences exceeds.

Who owns the most shares of Caris Life Sciences?

Caris Life Sciences’s largest shareholders are Sixth street partners management company (24.39M shares, 37.56%), Coatue management (10.14M shares, 15.62%), and Fmr (9.63M shares, 14.84%). Together, they hold 68.02% of Caris Life Sciences’s total shares outstanding.

Does Blackrock own Caris Life Sciences?

BlackRock is not among the top 10 institutional shareholders of Caris Life Sciences.

Who is Caris Life Sciences’s biggest shareholder by percentage of total assets invested?

Sixth street partners management company is Caris Life Sciences’s biggest shareholder by percentage of total assets invested, with 63.36% of its assets in 24.39M Caris Life Sciences shares, valued at 737.66M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools